Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01350362
What this trial is testing

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Noscira SA 306
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Ended earlyNCT01676935
What this trial is testing

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 349
Testing effectiveness (Phase 2)Study completedNCT00948259
What this trial is testing

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Noscira SA 30
Testing effectiveness (Phase 2)Ended earlyNCT00960531
What this trial is testing

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Testing effectiveness (Phase 2)Study completedNCT03748706
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Pain Therapeutics 13
Testing effectiveness (Phase 2)Ended earlyNCT00606476
What this trial is testing

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Testing effectiveness (Phase 2)UnknownNCT00174525
What this trial is testing

Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pharmacology Research Institute
Not applicableStudy completedNCT04570215
What this trial is testing

Digital Interventions in Neuro-Rehabilitation: Gotcha!

Who this might be right for
DementiaAlzheimer DiseaseAnomia
University College, London 48
Large-scale testing (Phase 3)Study completedNCT05686044
What this trial is testing

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Who this might be right for
Alzheimer Disease
Annovis Bio Inc. 351
Not applicableStudy completedNCT01937221
What this trial is testing

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentMild to Moderate Cognitive Impairment
Duke University 60
Large-scale testing (Phase 3)Study completedNCT02079246
What this trial is testing

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 1,463
Not applicableStudy completedNCT01825317
What this trial is testing

Effect of NeuroAD on Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 32
Large-scale testing (Phase 3)Ended earlyNCT01969136
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 403
Large-scale testing (Phase 3)Study completedNCT02585934
What this trial is testing

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Who this might be right for
Alzheimer's Disease
Axovant Sciences Ltd. 1,315
Not applicableNot Yet RecruitingNCT07673263
What this trial is testing

Effects of X Box Kinect 360 in Alzheimer's Disease

Who this might be right for
Alzheimer s Disease
Ziauddin University 38
Early research (Phase 1)Ended earlyNCT02220738
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 19
Testing effectiveness (Phase 2)Ended earlyNCT00334568
What this trial is testing

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 12
Post-approval studies (Phase 4)Study completedNCT00230568
What this trial is testing

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eisai Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00481520
What this trial is testing

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 72
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation